These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 12118113)

  • 21. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
    Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
    J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microvillous lymphomas are B-cell neoplasms that frequently express CD56.
    Hammer RD; Vnencak-Jones CL; Manning SS; Glick AD; Kinney MC
    Mod Pathol; 1998 Mar; 11(3):239-46. PubMed ID: 9521469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
    Liu YH; Xu FP; Zhuang HG; Lai KC; Xie D; Luo DL; Li L; Luo XL; Xu J; Zhang MH; Zhang F; Li HM
    Hum Pathol; 2008 Jun; 39(6):875-84. PubMed ID: 18440593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
    Almasri NM; Iturraspe JA; Braylan RC
    Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
    Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
    Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
    Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
    Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
    Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
    Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
    Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
    Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on Ki-67 expression.
    Saito B; Shiozawa E; Yamochi-Onizuka T; Adachi D; Nakamaki T; Tomoyasu S; Omine M; Mitsuya T; Takimoto M; Ota H
    Pathol Int; 2004 Sep; 54(9):667-74. PubMed ID: 15363034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
    Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
    APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?
    Bosga-Bouwer AG; van den Berg A; Haralambieva E; de Jong D; Boonstra R; Kluin P; van den Berg E; Poppema S
    Hum Pathol; 2006 May; 37(5):528-33. PubMed ID: 16647949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic and biological features define two types of follicular non-Hodgkin grade 3 lymphoma].
    Katzenberger T; Lohr A; Ott MM; Kalla J; Rosenwald A; Müller-Hermelink HK; Ott G
    Verh Dtsch Ges Pathol; 2000; 84():153-61. PubMed ID: 11217435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma.
    Uherova P; Ross CW; Schnitzer B; Singleton TP; Finn WG
    Am J Clin Pathol; 2001 Apr; 115(4):582-8. PubMed ID: 11293907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi.
    Morabito F; Gallamini A; Stelitano C; Callea V; Guglielmi C; Neri S; Lazzaro A; Orsucci L; Ilariucci F; Sacchi S; Vitolo U; Federico M
    Cancer; 2004 Oct; 101(7):1601-8. PubMed ID: 15378507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype".
    Kusumoto S; Kobayashi Y; Sekiguchi N; Tanimoto K; Onishi Y; Yokota Y; Watanabe T; Maeshima AM; Ishida T; Inagaki H; Matsuno Y; Ueda R; Tobinai K
    Am J Surg Pathol; 2005 Aug; 29(8):1067-73. PubMed ID: 16006802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas.
    Beà S; Colomo L; López-Guillermo A; Salaverria I; Puig X; Pinyol M; Rives S; Montserrat E; Campo E
    J Clin Oncol; 2004 Sep; 22(17):3498-506. PubMed ID: 15337798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases.
    Khalidi HS; Brynes RK; Browne P; Koo CH; Battifora H; Medeiros LJ
    Mod Pathol; 1998 Oct; 11(10):983-8. PubMed ID: 9796727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.